Reagan Bowlen, is a medicare enrolled "Physician Assistant" in Jeanette, Pennsylvania. Her current practice location is
2057 Pa-130, Jeanette, Pennsylvania. You can reach out to her office (for appointments etc.) via phone at
(724) 527-2700.
Reagan Bowlen is licensed to practice in Pennsylvania (license number MA061654) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1023626736.
Provider's Profile
Full Name | Reagan Bowlen |
---|
Gender | Female |
---|
Speciality | Physician Assistant |
---|
Location | 2057 Pa-130, Jeanette, Pennsylvania |
---|
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
NPI Data:
- NPI Number: 1023626736
- Provider Enumeration Date: 07/20/2020
- Last Update Date: 08/15/2023
Medicare PECOS Information:
- PECOS PAC ID: 7416372552
- Enrollment ID: I20200806000049
Medical Identifiers
Medical identifiers for Reagan Bowlen such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1023626736 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
363A00000X | Physician Assistant | MA061654 (Pennsylvania) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Reagan Bowlen is
enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Reagan Bowlen, 244 Ankrom Rd, Jefferson, PA 15344-4055 Ph: () - | Reagan Bowlen, 2057 Pa-130, Jeanette, PA 15644 Ph: (724) 527-2700 |
Reviews and Comments